In a report published Friday, Needham analyst Elliot Wilbur reiterated a Hold rating on NuPathe PATH.
In the report, Needham says "PATH announced 3Q13 financials and an update on the Zecuity launch preparations. The company continues to make progress, but no commercial partnership has been secured and given the cash runway of $10MM (as of 9/30/13) that only extends to January 2014, PATH is paring back expenses postponing the expected 4Q13 launch of Zecuity indefinitely until a partner and additional capital are secured. PATH expects to continue the validation of the Zecuity manufacturing processes and have launch supplies manufactured by the end of 2013. While the company's need for capital is urgent, we continue to believe a commercial partner can be secured to proceed with a 2014 Zecuity launch."
NuPath closed on Thursday at $1.86.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in